Since its establishment in November 2017, Arontier is an artificial
intelligence-driven drug discovery start-up company using bioinformatics,
pharmacogenomics for incurable and rare diseases.
Drug development is becoming unprofitable more than before. This can mainly
be attributed to large average development costs, low clinical trial drugs
success rate, and low ROI because of reduced healthcare expenditure and
focused on rare diseases. However, AI can be applied in drug discovery to make
the process faster significantly and statistically. As a result, innovative
technologies have been creating an environment where medical advances can
be quickly realized.
Based on our own unique technology and extensive data, we are constantly
challenging ourselves with a mission to conquer incurable diseases and deliver
healthy life and happiness to countless suffering patients.
Arontier is an activist and a realist to overcome nature of disease with
technology and innovation based on evidence from real world.
It is based on communication and consideration not only in the development
of new medicines but also on genetic editing along with various domestic
and foreign companies, experts and scholars. We regard human health and
happiness as the best value. Thank you.